Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50,690 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Complete Transurethral Resection on Oncologic Outcomes After Radiation Therapy for Muscle-Invasive Bladder Cancer.
Avolio PP, Kool R, Shayegan B, Marcq G, Black PC, Breau RH, Kim M, Busca I, Abdi H, Dawidek M, Uy M, Fervaha G, Cury FL, Sanchez-Salas R, Alimohamed N, Izawa J, Jeldres C, Rendon R, Siemens R, Kulkarni GS, Kassouf W. Avolio PP, et al. Among authors: kim m. Int J Radiat Oncol Biol Phys. 2024 Aug 24:S0360-3016(24)03292-9. doi: 10.1016/j.ijrobp.2024.08.036. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39186955 Free article.
Radiation-based Therapy for Muscle-invasive Bladder Cancer: Contemporary Outcomes Across Tertiary Centers.
Kool R, Marcq G, Breau RH, Black PC, Shayegan B, Kim M, Busca I, Abdi H, Dawidek MT, Uy M, Fervaha G, Cury FL, Alimohamed NS, Izawa JI, Jeldres C, Rendon R, Siemens DR, Kulkarni GS, Kassouf W. Kool R, et al. Among authors: kim m. Eur Urol Oncol. 2023 Dec;6(6):597-603. doi: 10.1016/j.euo.2023.03.004. Epub 2023 Mar 31. Eur Urol Oncol. 2023. PMID: 37005214
Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse Probability Treatment Weighted Analysis.
Kool R, Dragomir A, Kulkarni GS, Marcq G, Breau RH, Kim M, Busca I, Abdi H, Dawidek M, Uy M, Fervaha G, Cury FL, Alimohamed N, Izawa J, Jeldres C, Rendon R, Shayegan B, Siemens R, Black PC, Kassouf W. Kool R, et al. Among authors: kim m. Eur Urol Oncol. 2024 Dec;7(6):1350-1357. doi: 10.1016/j.euo.2024.01.014. Epub 2024 Feb 6. Eur Urol Oncol. 2024. PMID: 38326142
The Impact of Histologic Subtypes on Clinical Outcomes After Radiation-Based Therapy for Muscle-Invasive Bladder Cancer.
Halstuch D, Kool R, Marcq G, Breau RH, Black PC, Shayegan B, Kim M, Busca I, Abdi H, Dawidek MT, Uy M, Fervaha G, Cury FL, Alimohamed NS, Jeldres C, Rendon R, Brimo F, Siemens DR, Kulkarni GS, Kassouf W, Izawa JI. Halstuch D, et al. Among authors: kim m. J Urol. 2024 Nov;212(5):710-719. doi: 10.1097/JU.0000000000004160. Epub 2024 Jul 25. J Urol. 2024. PMID: 39051515
Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted Analysis.
Marcq G, Kool R, Dragomir A, Kulkarni GS, Breau RH, Kim M, Busca I, Abdi H, Dawidek M, Uy M, Fervaha G, Alimohamed N, Izawa J, Jeldres C, Rendon R, Shayegan B, Siemens R, Black PC, Cury FL, Kassouf W. Marcq G, et al. Among authors: kim m. J Clin Oncol. 2024 Oct 3:JCO2302718. doi: 10.1200/JCO.23.02718. Online ahead of print. J Clin Oncol. 2024. PMID: 39361935
2024 Canadian Surgery Forum: Sept. 25-28, 2024.
Li C, Guo M, Karimuddin A, Guo M, Li C, Karimuddin A, Sutherland J, Huo B, McKechnie T, Ortenzi M, Lee Y, Antoniou S, Mayol J, Ahmed H, Boudreau V, Ramji K, Eskicioglu C, de Jager P, Urbach D, Poole M, Abbad A, Al-Shamali H, Al-Faraj Z, Wen C, Pescarus R, Bechara R, Hong D, Park LJ, Marcucci M, Ofori S, Bogach J, Serrano PE, Simunovic M, Yang I, Cadeddu M, Marcaccio MJ, Borges FK, Nenshi R, Devereaux PJ, Urbanellis P, Douglas J, Nemeth E, Ellsmere J, Spence R, Cunningham J, Falk R, Skinner T, Ebert N, Galbraith L, Prins M, Joharifard S, Joos E, Orovec A, Lethbridge L, Spence R, Hoogerboord M, Stuart H, Bergeron AM, Yang I, Bogach J, Nguyen L, Reade C, Eiriksson L, Morais M, Hanley G, Mah S, Brar K, Seymour KA, Eckhouse SR, Sudan R, Greenberg JA, Portenier D, Jung JJ, Light A, Dingley B, Delisle M, Apte S, Mallick R, Hamilton T, Stuart H, Talbot M, McKinnon G, Jost E, Thiboutot E, Nessim C, Katote N, Drohan A, Spence R, Neumann K, Shi G, Leung R, Lim C, Van Oirschot M, Grant A, Knowles S, Van Koughnett JA, Brousseau K, Monette L, McIsaac D, Wherrett C, Mallick R, Workneh A, Ramsay T, Tinmouth A, Shaw J, Carrier FM, Fergusson D, Martel G, Cornacchia M, Ivankovic V, Mamalchi SA, Choi… See abstract for full author list ➔ Li C, et al. Among authors: kim m. Can J Surg. 2024 Nov 28;67(6suppl2):S77-S108. doi: 10.1503/cjs.012624. Print 2024 Nov-Dec. Can J Surg. 2024. PMID: 39609036 Free PMC article. No abstract available.
Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit.
Lamontagne F, Masse MH, Menard J, Sprague S, Pinto R, Heyland DK, Cook DJ, Battista MC, Day AG, Guyatt GH, Kanji S, Parke R, McGuinness SP, Tirupakuzhi Vijayaraghavan BK, Annane D, Cohen D, Arabi YM, Bolduc B, Marinoff N, Rochwerg B, Millen T, Meade MO, Hand L, Watpool I, Porteous R, Young PJ, D'Aragon F, Belley-Cote EP, Carbonneau E, Clarke F, Maslove DM, Hunt M, Chassé M, Lebrasseur M, Lauzier F, Mehta S, Quiroz-Martinez H, Rewa OG, Charbonney E, Seely AJE, Kutsogiannis DJ, LeBlanc R, Mekontso-Dessap A, Mele TS, Turgeon AF, Wood G, Kohli SS, Shahin J, Twardowski P, Adhikari NKJ; LOVIT Investigators and the Canadian Critical Care Trials Group. Lamontagne F, et al. N Engl J Med. 2022 Jun 23;386(25):2387-2398. doi: 10.1056/NEJMoa2200644. Epub 2022 Jun 15. N Engl J Med. 2022. PMID: 35704292 Clinical Trial.
50,690 results
You have reached the last available page of results. Please see the User Guide for more information.